➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

ATGAM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ATGAM

Patents:	6
Applicants:	1
BLAs:	1
Suppliers: see list	1

Patent Text Search: US Patents for ATGAM

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Pharmacia & Upjohn Company Llc	ATGAM	equine thymocyte immune globulin	INJECTION, SOLUTION	103676	1	1981-11-17	Start Trial	UNIVERSITY OF WYOMING (Laramie, WY)	2036-03-11			search
Pharmacia & Upjohn Company Llc	ATGAM	equine thymocyte immune globulin	INJECTION, SOLUTION	103676	1	1981-11-17	Start Trial	Beth Israel Deaconess Medical Center, Inc. (Boston, MA)	2039-02-26			search
Pharmacia & Upjohn Company Llc	ATGAM	equine thymocyte immune globulin	INJECTION, SOLUTION	103676	1	1981-11-17	Start Trial	Array BioPharma Inc. (Boulder, CO) Celgene Corporation (Summit, NJ)	2034-12-05			search
Pharmacia & Upjohn Company Llc	ATGAM	equine thymocyte immune globulin	INJECTION, SOLUTION	103676	1	1981-11-17	Start Trial	The Massachusetts Institute of Technology (Cambridge, MA)	2016-09-05			search
Pharmacia & Upjohn Company Llc	ATGAM	equine thymocyte immune globulin	INJECTION, SOLUTION	103676	1	1981-11-17	Start Trial	Bristol-Myers Squibb Company (Princeton, NJ)	2021-05-23			search
Pharmacia & Upjohn Company Llc	ATGAM	equine thymocyte immune globulin	INJECTION, SOLUTION	103676	1	1981-11-17	Start Trial	Peptimmune, Inc. (Cambridge, MA)	2024-05-07			search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ATGAM

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	1962880	Start Trial
South Korea	20070036062	Start Trial
Canada	2630364	Start Trial
Japan	4837880	Start Trial
Norway	332465	Start Trial
European Patent Office	1750741	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Mallinckrodt

Moodys

Colorcon

Boehringer Ingelheim

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.